Medicare Enrolled
Dr. Andrew Taylor, M.D.
Neurology · Foxboro, MA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Taylor from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Taylor?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Taylor
Dr. Andrew Taylor is a neurology specialist in Foxboro, MA, with 12 years of NPI registration. Based on federal Medicare data, Dr. Taylor performed 777 Medicare services across 655 unique beneficiaries.
Between the years covered by Open Payments, Dr. Taylor received a total of $7,440 from 69 pharmaceutical and/or device companies across 390 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Taylor is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 12 years in practice
▲ Top 19% volume in MA
$7,440 industry payments
Medicare Practice Summary
Medicare Utilization ↗777
Medicare services
Top 19% in MA for neurology
655
Unique beneficiaries
$118
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~65 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
273 | $102 | $312 |
| Electromyography of arm or leg muscles A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them. |
147 | $86 | $270 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
110 | $146 | $408 |
| New patient office visit, complex (60-74 min) | 78 | $175 | $540 |
| Nerve conduction study, 9-10 studies A diagnostic test that measures how well nerves send electrical signals. It involves performing 9 to 10 separate nerve conduction studies to evaluate nerve function. |
51 | $176 | $636 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
38 | $124 | $510 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
26 | $74 | $240 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
22 | $76 | $660 |
| Nerve conduction studies, 7-8 tests A series of 7 to 8 nerve conduction tests to evaluate how well nerves are sending signals to muscles. |
19 | $134 | $540 |
| Nerve conduction studies, 5-6 tests A series of 5 to 6 tests that measure how well nerves send electrical signals. The procedure evaluates nerve function and helps identify damage or dysfunction. |
13 | $118 | $408 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$7,440
Total received (2018-2024)
Avg $1,063/year across 7 years
Top 29% in MA for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
69
Companies
390
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,230 (97.2%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$210 (2.8%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,044
2023
$1,816
2022
$1,347
2021
$1,179
2020
$516
2019
$397
2018
$142
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
SK Life Science, Inc.
$348
ABBVIE INC.
$215
Lundbeck LLC
$180
Alexion Pharmaceuticals, Inc.
$159
PFIZER INC.
$131
Novartis Pharmaceuticals Corporation
$95
Celgene Corporation
$88
Amgen Inc.
$85
EMD Serono, Inc.
$59
CSL Behring
$51
UCB, Inc.
$48
Alnylam Pharmaceuticals Inc.
$48
ACADIA Pharmaceuticals Inc
$48
NEUROPACE, INC.
$46
Xeris Pharmaceuticals, Inc.
$45
Otsuka America Pharmaceutical, Inc.
$40
Genentech USA, Inc.
$35
Teva Pharmaceuticals USA, Inc.
$30
Mallinckrodt Hospital Products Inc.
$27
Averitas Pharma Inc.
$26
Amylyx Pharmaceuticals, Inc.
$24
TG Therapeutics, Inc.
$23
Biogen, Inc.
$22
Acorda Therapeutics, Inc
$21
Eisai Inc.
$19
AstraZeneca Pharmaceuticals LP
$18
Kedrion Biopharma, Inc.
$18
CATALYST PHARMACEUTICALS, INC.
$18
Takeda Pharmaceuticals U.S.A., Inc.
$17
Amneal Pharmaceuticals LLC
$17
MITSUBISHI TANABE PHARMA AMERICA, INC.
$16
Neurelis, Inc.
$14
Lilly USA, LLC
$14
Top 3 companies account for 36.4% of 2024 payments
All-time payments by company (2018-2024) ›
SK Life Science, Inc.
$809
Lundbeck LLC
$686
CSL Behring
$463
Novartis Pharmaceuticals Corporation
$438
Alexion Pharmaceuticals, Inc.
$394
PFIZER INC.
$298
ABBVIE INC.
$283
AbbVie Inc.
$255
Teva Pharmaceuticals USA, Inc.
$254
EMD Serono, Inc.
$254
Alnylam Pharmaceuticals Inc.
$217
Celgene Corporation
$216
Biogen, Inc.
$210
Amneal Pharmaceuticals LLC
$151
Xeris Pharmaceuticals, Inc.
$145
Mallinckrodt Hospital Products Inc.
$144
UCB, Inc.
$144
Amgen Inc.
$140
Allergan, Inc.
$128
Biohaven Pharmaceuticals, Inc.
$111
Acorda Therapeutics, Inc
$92
Neurocrine Biosciences, Inc.
$88
Lilly USA, LLC
$80
Averitas Pharma Inc.
$68
Avanir Pharmaceuticals, Inc.
$67
MITSUBISHI TANABE PHARMA AMERICA, INC.
$65
EISAI INC.
$61
CATALYST PHARMACEUTICALS, INC.
$60
Medtronic, Inc.
$51
Eisai Inc.
$50
ACADIA Pharmaceuticals Inc
$48
NEUROPACE, INC.
$46
GE HealthCare
$45
Almatica Pharma LLC
$42
Amylyx Pharmaceuticals, Inc.
$40
Otsuka America Pharmaceutical, Inc.
$40
Biohaven Pharmaceutical Holding Company Ltd.
$38
Merz Pharmaceuticals, LLC
$37
Catalyst Pharmaceuticals, Inc.
$37
LivaNova USA, Inc.
$36
Genentech USA, Inc.
$35
IMPEL PHARMACEUTICALS INC.
$35
ARGENX US, INC.
$34
Mitsubishi Tanabe Pharma America, Inc.
$34
Horizon Therapeutics plc
$33
Greenwich Biosciences, Inc.
$28
TG Therapeutics, Inc.
$23
ARBOR PHARMACEUTICALS, INC.
$23
E.R. Squibb & Sons, L.L.C.
$23
ANI Pharmaceuticals, Inc.
$22
GENZYME CORPORATION
$22
MDD US Operations, LLC
$21
GRT US Holding, Inc.
$20
AstraZeneca Pharmaceuticals LP
$18
Supernus Pharmaceuticals, Inc.
$18
Axsome Therapeutics, Inc.
$18
Kedrion Biopharma, Inc.
$18
Grifols USA, LLC
$18
Mylan Specialty L.P.
$17
Takeda Pharmaceuticals U.S.A., Inc.
$17
Adamas Pharmaceuticals, Inc.
$17
TG THERAPEUTICS, INC.
$17
Janssen Pharmaceuticals, Inc
$16
Avion Pharmaceuticals
$15
Neurelis, Inc.
$14
MERZ NORTH AMERICA, INC.
$14
SANOFI-AVENTIS U.S. LLC
$14
Kyowa Kirin, Inc.
$12
GE HEALTHCARE
$11
Top 3 companies account for 26.3% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ADUHELM · AIMOVIG · AJOVY · AMPYRA · AMVUTTRA · AMYVID · APOKYN · AUSTEDO · AVONEX · Aduhelm · Aimovig · Albuked · Austedo XR · BOTOX · BRIUMVI · Briviact · COMIRNATY · DAYBUE · DUOPA · Dhivy · EMGALITY · Enspryng · Epidiolex · FIRDAPSE · FYCOMPA · Fycompa · GILENYA · GIVLAARI · GLATIRAMER ACETATE · GOCOVRI · GRALISE · GVOKE PFS · Gamunex-C · HYQVIA · Hizentra · Horizant · INBRIJA · INGREZZA · INTELLIS ADAPTIVESTIM · KESIMPTA · KEVEYIS · LEMTRADA · LYVISPAH · Leqembi · MAVENCLAD · MAYZENT · Mavenclad · NAPRELAN · NORTHERA · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nayzilam · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONGENTYS · ONPATTRO · ONZETRA Xsail · PAXLOVID · PERCEPT PC BRAINSENSE · PLEGRIDY · PURIFIED CORTROPHIN GEL · Ponvory · QULIPTA · QUTENZA · Qutenza · RADICAVA · RELYVRIO · REXULTI · RNS Neurostimulator Kit · RYTARY · Radicava · Rystiggo · SOLIRIS · SPINRAZA · Sunosi · TROKENDI XR · TYSABRI · Trudhesa · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VNS - Sentiva · VNS Therapy SenTiva Model 1000 Generator · VUMERITY · VYEPTI · VYVGART · XCOPRI · XEOMIN · Xeomin · ZAVZPRET · ZEPOSIA · Zilbrysq
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (97%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Neurologists within 10 mi
710
Per 100K population
98.0
County median income
$126,497
Nearest hospital
NORWOOD HOSPITAL
9.1 mi
9.1 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Taylor is a clinical cardiology specialist, with above-average Medicare volume (top 19% in MA), with low-engagement industry engagement.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Taylor experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Taylor performed 273 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Taylor receive payments from pharmaceutical companies?
Yes. Dr. Taylor received a total of $7,440 from 69 companies across 390 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Taylor's costs compare to other neurologists in Foxboro?
Dr. Taylor's average Medicare payment per service is $118. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Taylor) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in Foxboro
Browse neurologists in Foxboro ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in MA
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in MA
Which MA neurologists receive the most from drug and device companies.
By company
SK Life Science, Inc. Payments to Doctors
See all physicians who received payments from SK Life Science, Inc.
By company
Lundbeck LLC Payments to Doctors
See all physicians who received payments from Lundbeck LLC.
By company
CSL Behring Payments to Doctors
See all physicians who received payments from CSL Behring.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology